Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients

		Keywords:		Vaccine

		Phase:		Phase 1

		Treatment ID#s:		VT1843 NCT00612001

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: Y Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		01/24/2010

		Tumor Types:		Anaplastic Astrocytoma Glioblastoma Multiforme Mixed Glioma Oligodendroglioma High Grade


		Comments:

		Treatment Type:		Immunological, Biological or Targeted Therapy.

		Contact:		UCLA Medical Center Linda M. Liau, MD, PhD Co-director, Brain Tumor Program David Geffen School of Medicine at UCLA 10833 Le Conte Avenue, CHS 74-145 Los Angeles, CA 90095 Phone:310-267-2621 Fax: 310-825-7245 Click here to send an email Website: neurosurgery.ucla.edu/

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By